Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-28

Clinical Trial Update: A Placebo-Controlled, Cross-Over Trial of Aripiprazole [Phase 4]

View source ↗

Summary

Phase 4, placebo-controlled, cross-over trial evaluating aripiprazole in schizophrenia. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: North Suffolk Mental Health Association | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2013-01-28